Nutex Health price to book ratio NUTX

Market value divided by the book value of the company's net assets, since 2017.

Today, Oct 23, 2026: 3.6×
9-year median: 13.8×
Against its 9-year history: 21st; percentile: 0 is its lowest day, 100 its highest
9-year range: 0.8× to 188×
Peer median: 1.9×

Nutex Health's price to book ratio is 3.6× as of Oct 23, 2026.

That is below its 9-year median of 13.8×, lower than on 79% of days in the last 9 years.

Over that time it ranged from 0.8× in Aug 2024 to 188× in Dec 2019.

The median for 10 credit services stocks of a similar size is 1.9×.

Price to book ratio over time

Open the interactive chart, with overlays and comparisons

Year by year

Year	End of year	Low	High
2026 so far	3.6×	1.9×	4.2×
2025	3.9×	2.4×	5.9×
2024	2.9×	0.8×	15.7×
2023	13.4×	13.0×	102×
2022	112×	7.8×	123×
2021	26.8×	14.4×	31.3×
2020	13.2×	10.3×	164×
2019	145×	2.3×	188×
2018	5.8×	5.8×	30.5×
2017	10.7×	10.7×	58.9×

Against its peers

Companies in Financial - Credit Services nearest Nutex Health's size, closest first, today.

Company	Price to book ratio
NUTXNutex Health	3.6×
LQDTLiquidity Services	6.0×
ATLCAtlanticus	1.9×
PGYPagaya Technologies	2.7×
HAPNHappen	1.0×
WDWalker & Dunlop	0.7×
JCAPJefferson Capital	2.5×
PWPPerella Weinberg Partners	n/m
WUWestern Union CO	2.2×
ECPGEncore Capital	1.9×
AGMFederal Agricultural Mortgage	1.2×
Peer median	1.9×

What the price to book ratio tells you

Market value divided by the accounting value of the company's net assets. Below 1 means the market values the business at less than what it owns on paper.

Book value misses brands, software and people, so asset-light companies always look expensive on it. Most useful for banks and industrials.

More on Nutex Health

Valuation data, not investment advice. Prices as of Oct 23, 2026. Reported figures come from the company's filings with the SEC.